1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
CT findings according to arytenoid mobility in pathologically positive CAUs
Pathologically PositiveTotal
CT PositiveCT Negative
Mobile (n = 34)2/5 (40%)1/29 (3.4%)3/34 (8.8%)
Impaired (n = 15)6/11 (54.5%)2/4 (50%)8/15 (53.3%)
Fixed (n = 11)5/6 (83.3%)4/5 (80%)9/11 (81.8%)
Total13/22 (59%)7/38 (18.4%)20/60 (33.3%)
  • Note:—CAUs indicate cricoarytenoid units.